QAdvis and Scandinavian CRO join Aurevia to strengthen clinical research and regulatory expertise
In January 2025, the Aurevia brand was established when Labquality, Artimed, Clinical Consulting,...
Meet us at ESCMID 2025 in Vienna
This year the European Society for Clinical Microbiology and Infectious Diseases, ESCMID Global,...
Aurevia appoints Jonna Pelanti as the new Head of EQA business area
We are delighted to announce the appointment of the new Head of the EQA business area Jonna Pelanti...
Meet us at BioMedica in Dublin
Aurevia’s international EQA team welcomes you to visit our exhibition booth A18 at BioMedica, which...
Aurevia appoints Ulrika Hammarström as the new Head of CRO business area
We are delighted to announce the appointment of the new Head of the CRO business area Ulrika...
Introducing the EQA Pilot Studies 2025
At Aurevia, we actively follow the development of laboratory medicine as we want to produce...
Aurevia appoints Anna-Karin Alm as the new Head of the QA/RA business area
We are delighted to announce the appointment of the new Head of the QA/RA business area Anna-Karin...
Introducing Aurevia
On January 7th, Labquality and Artimed, Clinical Consulting, Kasve and Prisma CRO merge under the...
New EQA schemes for 2025
We launch 5-10 new external quality assessment schemes annually. We closely monitor diagnostic...
Patient Safety: The Cornerstone of Healthcare
Happy World Patient Safety Day!
EQA Program 2025
We proudly present the new external quality assessment program for 2025. The program includes over...
Does your device require a clinical investigation?
Are you developing a product intended to diagnose, treat, or prevent medical conditions? If so,...